Ybrain Inc.
13
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
7.7%
1 terminated/withdrawn out of 13 trials
83.3%
-3.2% vs industry average
15%
2 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Treating Traumatic Brain Injury With Transcranial Direct Current Stimulation
Role: collaborator
Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease
Role: collaborator
tDCS in Depression in Perinatal Women
Role: collaborator
Effect of Simultaneous Application of HD-tDCS and Robot-assisted Gait Training on Gait Function in Stroke Patients
Role: collaborator
The Efficacy and Safety of tDCS in Patients With Mild Dementia
Role: lead
The Efficacy and Safety of At-home Transcutaneous Electrical Nerve Stimulation in Insomnia
Role: lead
The Efficacy and Safety of tDCS in Patients With Mild to Moderate Major Depressive Disorder
Role: lead
Effect of Self-administered tDCS in Patients With MDD
Role: collaborator
tDCS(Transcranial Direct Current Stimulation) Efficacy in Bipolar Depression : RCT Study
Role: collaborator
Study of tDCS for Mild Cognitive Impairment
Role: collaborator
The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder
Role: lead
A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease
Role: collaborator
A Pilot Study of tDCS for Mild Cognitive Impairment
Role: collaborator
All 13 trials loaded